Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun 18;14(12):3004.
doi: 10.3390/cancers14123004.

Ability of Delta Radiomics to Predict a Complete Pathological Response in Patients with Loco-Regional Rectal Cancer Addressed to Neoadjuvant Chemo-Radiation and Surgery

Affiliations

Ability of Delta Radiomics to Predict a Complete Pathological Response in Patients with Loco-Regional Rectal Cancer Addressed to Neoadjuvant Chemo-Radiation and Surgery

Valerio Nardone et al. Cancers (Basel). .

Abstract

We performed a pilot study to evaluate the use of MRI delta texture analysis (D-TA) as a methodological item able to predict the frequency of complete pathological responses and, consequently, the outcome of patients with locally advanced rectal cancer addressed to neoadjuvant chemoradiotherapy (C-RT) and subsequently, to radical surgery. In particular, we carried out a retrospective analysis including 100 patients with locally advanced rectal adenocarcinoma who received C-RT and then radical surgery in three different oncological institutions between January 2013 and December 2019. Our experimental design was focused on the evaluation of the gross tumor volume (GTV) at baseline and after C-RT by means of MRI, which was contoured on T2, DWI, and ADC sequences. Multiple texture parameters were extracted by using a LifeX Software, while D-TA was calculated as percentage of variations in the two time points. Both univariate and multivariate analysis (logistic regression) were, therefore, carried out in order to correlate the above-mentioned TA parameters with the frequency of pathological responses in the examined patients' population focusing on the detection of complete pathological response (pCR, with no viable cancer cells: TRG 1) as main statistical endpoint. ROC curves were performed on three different datasets considering that on the 21 patients, only 21% achieved an actual pCR. In our training dataset series, pCR frequency significantly correlated with ADC GLCM-Entropy only, when univariate and binary logistic analysis were performed (AUC for pCR was 0.87). A confirmative binary logistic regression analysis was then repeated in the two remaining validation datasets (AUC for pCR was 0.92 and 0.88, respectively). Overall, these results support the hypothesis that D-TA may have a significant predictive value in detecting the occurrence of pCR in our patient series. If confirmed in prospective and multicenter trials, these results may have a critical role in the selection of patients with locally advanced rectal cancer who may benefit form radical surgery after neoadjuvant chemoradiotherapy.

Keywords: MRI; neoadjuvant chemo-radiation; rectal cancer; texture analysis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Box plot of the D-TA ADC GLCM Entropy in the training dataset (left) and validation datasets (right).
Figure 2
Figure 2
ROC Curve for the prediction of pCR (TRG 1) for training dataset (left) and validation datasets (right).
Figure 3
Figure 3
The cut-off of ADC GLCM Entropy calculated on the training dataset was equal to −0.10. Using this cut-off, the sensibility of the model in the training and in the two validation datasets, respectively, was 70%, 73%, and 100%, the specificity of the models was 74%, 66.7%, and 80%, and the accuracy of the model was 73%, 72.7%, and 80%.

Similar articles

Cited by

References

    1. van Gijn W., Marijnen C.A., Nagtegaal I.D., Kranenbarg E.M., Putter H., Wiggers T., Rutten H.J., Pahlman L., Glimelius B., van de Velde C.J., et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol. 2011;12:575–582. doi: 10.1016/S1470-2045(11)70097-3. - DOI - PubMed
    1. Sauer R., Liersch T., Merkel S., Fietkau R., Hohenberger W., Hess C., Becker H., Raab H.R., Villanueva M.T., Witzigmann H., et al. Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: Results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years. J. Clin. Oncol. 2012;30:1926–1933. doi: 10.1200/JCO.2011.40.1836. - DOI - PubMed
    1. Sebag-Montefiore D., Stephens R.J., Steele R., Monson J., Grieve R., Khanna S., Quirke P., Couture J., de Metz C., Myint A.S., et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): A multicentre, randomised trial. Lancet. 2009;373:811–820. doi: 10.1016/S0140-6736(09)60484-0. - DOI - PMC - PubMed
    1. Granata V., Faggioni L., Grassi R., Fusco R., Reginelli A., Rega D., Maggialetti N., Buccicardi D., Frittoli B., Rengo M., et al. Structured reporting of computed tomography in the staging of colon cancer: A Delphi consensus proposal. Radiol. Med. 2022;127:21–29. doi: 10.1007/s11547-021-01418-9. - DOI - PMC - PubMed
    1. Link K.H., Kornmann M., Staib L., Kreuser E.D., Gaus W., Röttinger E., Suhr P., Maulbecker-Armstrong C., Danenberg P., Danenberg K., et al. Patient-centered developments in colon- and rectal cancer with a multidisciplinary international team: From translational research to national guidelines. World J. Gastrointest. Surg. 2021;13:1597–1614. doi: 10.4240/wjgs.v13.i12.1597. - DOI - PMC - PubMed